episode 2: which patients should receivetargeted biologic therapy and when?
Published 4 months ago • 49 plays • Length 20:45Download video MP4
Download video MP3
Similar videos
-
36:19
leveraging the power of targeted biologic therapy in severe asthma: do you know how and for whom?
-
25:48
expert insights on when to use targeted biologic therapy for patients with eosinophilic esophagitis
-
24:38
uncontrolled, moderate to severe asthma: identifying eligible patients for targeted biologic therapy
-
2:18:22
the pathogenesis of inflammatory dermatologic disorders and rationale for targeted biologic therapy
-
56:22
selecting targeted treatment for patients with uncontrolled, moderate to severe asthma
-
1:53:26
three rs for modern myeloma care
-
1:25:12
a guide for selection, sequencing, and optimal use of her2-targeted therapies in her2 breast cancer
-
33:59
initiating biologic therapy -- strategies to reduce the risks of complications
-
7:21
biologic drugs and biosimilars
-
2:25
eosinophilic asthma and its treatment with biologic therapy
-
5:39
side effects of biologic medications
-
28:29
addressing unmet needs in ra: a physician-patient discussion
-
54:38
bcma antibodies and cellular therapies in rrmm
-
5:44
combination therapies and real world treatment for pbc patients - adriaan van der meer
-
35:50
a visual guide to overcoming individual and systemic barriers to hiv care and treatment
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
1:02:23
webinar: biologic therapy for patients with severe asthma
-
31:42
expert insights on the rationale for targeting epithelial alarmins in severe asthma
-
10:17
risk of infections during conventional and biologic therapy | ricardo romiti, md, phd | brazil
-
12:53
biologic therapy should never be stopped, or should it?
-
1:14
when treatment is complete - avid if2
-
53:53
severe asthma: directing new treatment approaches at the airway epithelium